Brain Korea 21 Project for Medicine, Yonsei University Department of Biochemistry and Molecular Biology, Center for Chronic Metabolic Disease Research, College of Medicine, Yonsei University
Soo Jung CHOI
Graduate School of Life Sciences and Biotechnology, Korea University
Seung-Taik LIM
Graduate School of Life Sciences and Biotechnology, Korea University
Hye Kyung KIM
Department of Food and Biotechnology, Hanseo University
Young Jun KIM
Department of Food and Biotechnology, Korea University
Ho-Geun YOON
Department of Biochemistry and Molecular Biology, Center for Chronic Metabolic Disease Research, College of Medicine, Yonsei University
Dong-Hoon SHIN
Department of Food and Biotechnology, Korea University
Published: February 23, 2008Received: July 30, 2007Available on J-STAGE: -Accepted: November 14, 2007
Advance online publication: February 07, 2008
Revised: -
In this study, our aim was to clarify the ameliorative effects of zeatin, a development hormone in plants. Zeatin mitigated cognitive deficits and showed AChE inhibition in scopolamine (Scop)-induced mice following 21 d of zeatin treatment. After administration of Scop for 30 min, each mouse performed Y-maze and step-down latency tasks as a check on immediate against cognitive function. The results showed that zeatin administration attenuated Scop-induced memory damage and decreased AChE activity in the mice. This suggests that zeatin might be useful for protecting cognitive dysfunction, as well as for reducing the activation of AChE in dementia.
References (21)
Related articles (0)
Figures (0)
Content from these authors
Supplementary material (0)
Result List ()
Cited by
This article cannot obtain the latest cited-by information.